Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Didanosine intensification in NRTI-experienced patients.
Currier
J
J
D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D019562:Viral Load
D010919:Placebos; D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine